NuCana (NCNA) Interest Expenses (2025)

NuCana's (NCNA) quarterly Interest Expenses came in at $33.6 million in Q4 2025, up 299.42% quarter-over-quarter from -$16.9 million in Q2 2025.

NuCana (NCNA) Interest Expenses (2025) Analysis & Trends

NuCana has disclosed Interest Expenses across 1 years of filings, most recently posting $33.6 million for Q4 2025.

Interest Expenses for Q4 2025 came in at $33.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $16.8 million (changed N/A YoY), and the FY2025 annual result was $16.7 million, changed N/A from the prior year.
Interest Expenses came in at $33.6 million for Q4 2025 at NuCana, up from -$16.9 million in the prior quarter.
In the past five years, Interest Expenses ranged from a high of $33.6 million in Q4 2025 to a low of -$16.9 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-5.50 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-332,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	61,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-5.58 Mn
10	NuCana	27.79 Bn	27.79 Bn	-	33.65 Mn

Download Data